NEW YORK, Feb 26 – Pharmacopeia of Princeton, NJ, said Monday it would combine its four life science software units into a single entity, effective June 1.

“We’ve been acquiring different software businesses all related to drug discovery and chemical development, so we’re going to continue doing what we do, which is design and sell software to help our customers discover drugs and develop chemicals, but now we’ll just do it under one name since all the products are basically related,” Sue Rodney, manager of investor relations at Pharmacopeia, told GenomeWeb.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.